176 related articles for article (PubMed ID: 7074214)
1. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complex.
Teitel JM; Bauer KA; Lau HK; Rosenberg RD
Blood; 1982 May; 59(5):1086-97. PubMed ID: 7074214
[TBL] [Abstract][Full Text] [Related]
2. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Wada K; Niwano H; Shibata A
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):813-8. PubMed ID: 1336986
[TBL] [Abstract][Full Text] [Related]
3. Changes in plasma levels of prothrombin fragment F 1 + 2 in cases of disseminated intravascular coagulation.
Asakura H; Shiratori Y; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Acta Haematol; 1993; 89(1):22-5. PubMed ID: 8480481
[TBL] [Abstract][Full Text] [Related]
4. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
Teitel JM; Rosenberg RD
J Clin Invest; 1983 May; 71(5):1383-91. PubMed ID: 6222069
[TBL] [Abstract][Full Text] [Related]
5. Thrombin generation, thrombin-antithrombin complex, and prothrombin fragment F1+2 as biomarkers for hypercoagulability in cancer patients.
Lundbech M; Krag AE; Christensen TD; Hvas AM
Thromb Res; 2020 Feb; 186():80-85. PubMed ID: 31918352
[TBL] [Abstract][Full Text] [Related]
6. Relationship between changes in F1+2 and TAT levels and blood coagulation early after prosthetic valve replacement.
Nakamura K; Toyohira H; Kariyazono H; Yamada K; Moriyama Y; Taira A
Thromb Res; 1997 Apr; 86(2):161-71. PubMed ID: 9175237
[TBL] [Abstract][Full Text] [Related]
7. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of hypercoagulable state in patients with malignancies by using prothrombin fragment F1 + 2].
Nakagawa K; Tsuji H; Yamada K; Yamada Y; Masuda H; Yamagami M; Yoneda M; Takada O; Sawada S; Kitani T
Rinsho Ketsueki; 1992 Nov; 33(11):1666-72. PubMed ID: 1469781
[TBL] [Abstract][Full Text] [Related]
9. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
Boisclair MD; Lane DA; Philippou H; Sheikh S; Hunt B
Thromb Haemost; 1993 Aug; 70(2):253-8. PubMed ID: 8236130
[TBL] [Abstract][Full Text] [Related]
10. Increased ratio of soluble fibrin formation/thrombin generation in patients with DIC.
Kushimoto S; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Seki Y; Hatada T; Imai H; Nobori T;
Clin Appl Thromb Hemost; 2012 Nov; 18(6):628-32. PubMed ID: 22751910
[TBL] [Abstract][Full Text] [Related]
11. Thrombin-antithrombin complex and the prothrombin fragment in arterial and venous blood of patients with peripheral arterial disease.
Hering J; Amann B; Angelkort B; Rottmann M
Vasa; 2003 Nov; 32(4):193-7. PubMed ID: 14694767
[TBL] [Abstract][Full Text] [Related]
12. Prothrombin activation fragment 1 + 2 and thrombin-antithrombin-III complexes in plasma of patients with essential arterial hypertension.
Kłoczko J; Wojtukiewicz MZ; Galar M; Tarasów E; Jaromin J; Bielawiec M
Pol J Pharmacol; 1996; 48(2):233-5. PubMed ID: 9112658
[TBL] [Abstract][Full Text] [Related]
13. [Dynamics of thrombin-antithrombin-III complex (TAT-III) and prothrombin fragments F1 + 2 during labour with and without aprotinin administration].
Kühnert M; Stein W; Woernle F; Tekesin I; Hellmeyer L; Schmidt S
Z Geburtshilfe Neonatol; 2004 Jun; 208(3):98-109. PubMed ID: 15229817
[TBL] [Abstract][Full Text] [Related]
14. Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimen.
Haushofer A; Halbmayer WM; Dittel M; Prachar H; Mlczoch J; Fischer M
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):697-706. PubMed ID: 7865675
[TBL] [Abstract][Full Text] [Related]
15. Thrombin generation mediators and markers in sepsis-associated coagulopathy and their modulation by recombinant thrombomodulin.
Hoppensteadt D; Tsuruta K; Cunanan J; Hirman J; Kaul I; Osawa Y; Fareed J
Clin Appl Thromb Hemost; 2014 Mar; 20(2):129-35. PubMed ID: 23804232
[TBL] [Abstract][Full Text] [Related]
16. Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin.
Anderson PJ; Bock PE
J Biol Chem; 2003 Nov; 278(45):44489-95. PubMed ID: 12939270
[TBL] [Abstract][Full Text] [Related]
17. Effects of activation peptide bond cleavage and fragment 2 interactions on the pathway of exosite I expression during activation of human prethrombin 1 to thrombin.
Anderson PJ; Nesset A; Bock PE
J Biol Chem; 2003 Nov; 278(45):44482-8. PubMed ID: 12939269
[TBL] [Abstract][Full Text] [Related]
18. Meizothrombin formation during factor Xa-catalyzed prothrombin activation. Formation in a purified system and in plasma.
Tans G; Janssen-Claessen T; Hemker HC; Zwaal RF; Rosing J
J Biol Chem; 1991 Nov; 266(32):21864-73. PubMed ID: 1939210
[TBL] [Abstract][Full Text] [Related]
19. New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK.
Martin PD; Malkowski MG; Box J; Esmon CT; Edwards BF
Structure; 1997 Dec; 5(12):1681-93. PubMed ID: 9438869
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation.
Simioni P; Scarano L; Gavasso S; Sardella C; Girolami B; Scudeller A; Girolami A
Br J Haematol; 1996 Feb; 92(2):435-41. PubMed ID: 8603014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
